Company Filing History:
Years Active: 2002-2004
Title: Jan Svartengren: Innovator in Pharmaceutical Formulations
Introduction
Jan Svartengren is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of combination formulations for treating diseases related to the 5-HT receptor. With a total of 2 patents to his name, Svartengren's work is paving the way for innovative treatment methods.
Latest Patents
One of Jan Svartengren's latest patents is focused on a pharmaceutical combination formulation and method of treatment involving the 5-HT receptor. This invention relates to a method of preventing or treating diseases associated with the 5-HT receptor. It involves administering a 5-HT receptor agonist and a 5-HT receptor antagonist to a human or animal subject in need, in sufficient amounts to provide a therapeutic effect. Additionally, the invention includes a pharmaceutical composition that comprises an effective amount of this combination, along with a pharmaceutically acceptable carrier.
Career Highlights
Jan Svartengren is currently associated with Biovitrum AB, a company known for its focus on biotechnology and pharmaceuticals. His work at Biovitrum has allowed him to explore innovative solutions in the treatment of various medical conditions.
Collaborations
Throughout his career, Svartengren has collaborated with notable colleagues such as Kjell S Sakariassen and Patrizia Caldirola. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Jan Svartengren's contributions to pharmaceutical innovations highlight the importance of research in developing effective treatment methods. His work continues to influence the field and offers promising solutions for patients in need.